1. Patients launch a $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
ME/CFS and Beating the Clock
For Jody Smith, the ticking of a clock was enough at one time to chase her back to her bed. But with the passage of time, she has been able to reclaim her living room ...
Discuss the article on the Forums.

Drugs effective agaist xmrv type viruses(mlv)

Discussion in 'XMRV Research and Replication Studies' started by Gerwyn, May 24, 2010.

  1. Gerwyn

    Gerwyn Guest

    ournal of Virology, October 1999, p. 8813-8816, Vol. 73, No. 10
    0022-538X/99/$04.00+0
    Copyright 1999, American Society for Microbiology. All rights reserved.
    Efficacy of Antiretroviral Agents against Murine Replication-Competent Retrovirus Infection in Human Cells
    Sharon K. Powell,* Moria Artlip, Michele Kaloss, Scott Brazinski, Russette Lyons, Gerard J. McGarrity, and Edward Otto

    Genetic Therapy, Inc., a Novartis Company, Gaithersburg, Maryland 20878

    Received 24 March 1999/Accepted 7 July 1999

    ABSTRACT
    Top
    Abstract
    Text
    References

    Retroviral vectors for gene therapy are designed to minimize the occurrence of replication-competent retrovirus (RCR); nonetheless, it is possible that a vector-derived RCR could establish an infection in a patient. Since the efficacy of antiretroviral agents can be impacted by interactions between virus, host cell, and drug, five commonly used antiretroviral drugs were evaluated for their abilities to inhibit the replication of a murine leukemia virus (MLV)-derived RCR in human cells. The results obtained indicate that the combination of nucleoside analogs zidovudine and dideoxyinosine with the protease inhibitor indinavir effectively inhibits MLV-derived RCR replication in three human cell lines. In addition, MLV-derived RCR was found to be inherently resistant to the nucleoside analogs lamivudine and stavudine, suggesting that mutations conferring resistance to nucleoside analogs in human immunodeficiency virus type 1 have the same effect even in an alternative viral backbone.
  2. jace

    jace Off the fence

    Messages:
    855
    Likes:
    170
    England
    Zidovudine (Azidothymidine, AZT, ZDV , Retrovir, Retrovis)
    Dideoxyinosine (2’,3’-Dideoxyinosine, hydrate, DDI, Didanosine, Didanosine (JAN/USAN), Dideoxyinosine, Inosine, 2’,3’-dideoxy-, Videx, Videx (TN), Videx EC, ddI, Did)
    indinavir (Crixivan)

    I'm sure this site http://www.aidsinfonet.org/ has been linked to before on PR, but it's the first time I've seen it, and it sure is useful. There is a search box at the top right hand side, info on anything retroviral and more.

    I wonder whether we could somehow organise a retroviral trial? We would need physicians on board. As Dr Coffin said recently, a retroviral study, properly configured, is what is needed to prove or disprove XMRV causation in Myalgic Encephalomylitis

See more popular forum discussions.

Share This Page